Clinical Trial Update: Samsung Medical Center-Lymphoma Cohort Study [NA]

View source ↗

Summary

The Samsung Medical Center lymphoma cohort study (NCT00822731) has completed, with lymphoma as the condition and Samsung Medical Center listed as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Samsung Medical Center | Conditions: Lymphoma | NA | Status: COMPLETED